Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. 1989

R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
Unité de Recherche sur les Fonctions Intestinales, le Métabolisme et la Nutrition (INSERM U.290), Hôpital Saint-Lazare, Paris, France.

Twenty-eight patients with chronic idiopathic dyspepsia defined by the presence of chronic unexplained symptoms suggestive of gastric stasis and directly related to food ingestion were included in this prospective study. Gastric emptying of the liquid and solid phases of a meal was quantified by a dual-isotope method, and symptoms were evaluated by a diary and a visual analog scale. Delay in gastric emptying was evidenced in 59% of the dyspeptic patients; it occurred with liquids in more cases than solids. Quantitative and qualitative evaluation of symptoms was of no practical value in predicting the presence of objective stasis. The dyspeptic patients were included in a double-blind randomized controlled trial of cisapride, a new gastrokinetic drug devoid of central antiemetic effects. After six weeks of cisapride treatment, all patients with initially abnormal gastric emptying rates for liquids, and all but one for solids returned to normal ranges, and significant differences between cisapride and placebo groups were observed for half emptying times of both solids (136 +/- 16 min vs 227 +/- 32 min; P less than 0.02) and liquids (61 +/- 4 min vs 132 +/- 37 min; P less than 0.01). Cisapride also significantly improved dyspeptic symptom scores at weeks 3 and 6 of treatment as compared to those measured before treatment. Nevertheless, the decrease in global diary score was significantly higher than that seen with placebo at week 3 (-16 +/- 6 vs -1 +/- 9; P less than 0.05), but not at week 6 (-18 +/- 5 vs -10 +/- 8).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010880 Piperidines A family of hexahydropyridines.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1993, Scandinavian journal of gastroenterology. Supplement,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1987, Clinical therapeutics,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1979, Digestion,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
February 1997, Alimentary pharmacology & therapeutics,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
June 1995, Scandinavian journal of gastroenterology,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1993, Scandinavian journal of gastroenterology. Supplement,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1993, Scandinavian journal of gastroenterology. Supplement,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1992, Scandinavian journal of gastroenterology,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
January 1997, Journal of gastroenterology and hepatology,
R Jian, and F Ducrot, and A Ruskone, and S Chaussade, and J C Rambaud, and R Modigliani, and J D Rain, and J J Bernier
March 1995, The American journal of gastroenterology,
Copied contents to your clipboard!